Last reviewed · How we verify
NCT06923982
The Effect of Using Virtual Reality Glasses on Post-Care Pain and Comfort Level in Intensive Care Patients
NA trial testing virtual reality, experimental group in Copd in 60 participants. Completed in 15 January 2024.
31 December 2022
Quick facts
| Lead sponsor | Çankırı Karatekin University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 60 |
| Start date | 1 July 2022 |
| Primary completion | 31 December 2022 |
| Estimated completion | 15 January 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- virtual reality, experimental group
- control group — full drug profile →
Conditions studied
- Copd — all drugs for Copd →
- Heart Failure — all drugs for Heart Failure →
- Intensive Care Unit Syndrome — all drugs for Intensive Care Unit Syndrome →
- Renal Failure — all drugs for Renal Failure →
Sponsor
Çankırı Karatekin University
Who can join
Adults 18 to 65, any sex, with Copd or Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to determine the level of pain and comfort associated with the implementation of virtual reality prior to nursing care in patients undergoing treatment in the intensive care unit. The research will be conducted in the Internal Medicine Intensive Care Unit of a university hospital.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06923982
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Copd
Currently open trials in the same condition.
- NCT06461403 — Inhaler Trainer Efficacy Study · NA · recruiting
- NCT07285642 — Brain and Peripheral Muscle Oxygenation in Patients With Chronic Obstructive Pulmonary Disease · NA · recruiting
- NCT07027852 — My Lung Health Coach-A Virtual COPD Self-management Support Program Integrated Into the Electronic Patient Record · NA · recruiting
- NCT06286072 — The Effect of Education and Reminder Messages on the Fatigue Level of Individuals With COPD · NA · recruiting
- NCT06304207 — Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease · NA · recruiting
Other Çankırı Karatekin University trials
Trials by the same sponsor.
- NCT07326267 — School-Based Sensory Processing and Daily Living Skills-Focused Occupational Therapy Program · NA · not yet recruiting
- NCT07512544 — Building Sustainability Competencies in Future Nurses · NA · not yet recruiting
- NCT07266870 — Effect of CORE on Knowledge and Attitude Levels Regarding Pain Assessment · NA · completed
- NCT07306468 — Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life · recruiting
- NCT07207655 — Knowledge and Beliefs of Hearing Impaired Individuals Regarding Human Papillomavirus (HPV) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06923982 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Çankırı Karatekin University
- Last refreshed: 11 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06923982.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing